Cargando…
IFNγ is a central node of cancer immune equilibrium
Tumors in immune equilibrium are held in balance between outgrowth and destruction by the immune system. The equilibrium phase defines the duration of clinical remission and stable disease, and escape from equilibrium remains a major clinical problem. Using a non-replicating HSV-1 vector expressing...
Autores principales: | Walsh, Michael J., Stump, Courtney T., Kureshi, Rakeeb, Lenehan, Patrick, Ali, Lestat R., Dougan, Michael, Knipe, David M., Dougan, Stephanie K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214249/ https://www.ncbi.nlm.nih.gov/pubmed/36881506 http://dx.doi.org/10.1016/j.celrep.2023.112219 |
Ejemplares similares
-
Blockade of innate inflammatory cytokines TNFα, IL-1β, or IL-6 overcomes virotherapy-induced cancer equilibrium to promote tumor regression
por: Walsh, Michael J, et al.
Publicado: (2023) -
DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunity
por: Kureshi, Rakeeb, et al.
Publicado: (2023) -
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer
por: Ali, Lestat R., et al.
Publicado: (2023) -
Correction: PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer
por: Ali, Lestat R., et al.
Publicado: (2023) -
Neoleukin-2 enhances anti-tumour immunity downstream of peptide vaccination targeted by an anti-MHC class II VHH
por: Crowley, Stephanie J., et al.
Publicado: (2020)